- Home
- SHIP vs GNFT Comparison
SHIP vs GNFT Comparison
Compare SHIP & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- GNFT
- Stock Information
- Founded
- SHIP 2008
- GNFT 1999
- Country
- SHIP Greece
- GNFT France
- Employees
- SHIP N/A
- GNFT N/A
- Industry
- SHIP Marine Transportation
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHIP Consumer Discretionary
- GNFT Health Care
- Exchange
- SHIP Nasdaq
- GNFT Nasdaq
- Market Cap
- SHIP 127.2M
- GNFT 186.3M
- IPO Year
- SHIP 2007
- GNFT 2019
- Fundamental
- Price
- SHIP $6.93
- GNFT $3.75
- Analyst Decision
- SHIP Strong Buy
- GNFT Strong Buy
- Analyst Count
- SHIP 1
- GNFT 1
- Target Price
- SHIP $11.00
- GNFT $13.00
- AVG Volume (30 Days)
- SHIP 102.3K
- GNFT 3.8K
- Earning Date
- SHIP 08-05-2025
- GNFT 04-24-2025
- Dividend Yield
- SHIP 10.97%
- GNFT N/A
- EPS Growth
- SHIP 48.17
- GNFT N/A
- EPS
- SHIP 1.26
- GNFT 0.03
- Revenue
- SHIP $153,372,000.00
- GNFT $73,187,701.00
- Revenue This Year
- SHIP N/A
- GNFT $15.98
- Revenue Next Year
- SHIP $21.78
- GNFT N/A
- P/E Ratio
- SHIP $5.35
- GNFT $120.71
- Revenue Growth
- SHIP 17.53
- GNFT 105.01
- 52 Week Low
- SHIP $4.78
- GNFT $2.55
- 52 Week High
- SHIP $12.65
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- SHIP 53.50
- GNFT 44.52
- Support Level
- SHIP $6.32
- GNFT $3.44
- Resistance Level
- SHIP $6.60
- GNFT $3.81
- Average True Range (ATR)
- SHIP 0.22
- GNFT 0.17
- MACD
- SHIP -0.03
- GNFT -0.00
- Stochastic Oscillator
- SHIP 57.93
- GNFT 56.65
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.